Synthesis and Biological Evaluation of 1‐methyl‐1h‐indole–pyrazoline Hybrids As Potential Tubulin Polymerization Inhibitors

Ya-Liang Zhang,Ya-Juan Qin,Dan-Jie Tang,Meng-Ru Yang,Bo-Yan Li,Yan-Ting Wang,Hong-Yu Cai,Bao-Zhong Wang,Hai-Liang Zhu
DOI: https://doi.org/10.1002/cmdc.201600137
IF: 3.54
2016-01-01
ChemMedChem
Abstract:A series of 1-methyl-1H-indole-pyrazoline hybrids were designed, synthesized, and biologically evaluated as potential tubulin polymerization inhibitors. Among them, compound e19 [5-(5-bromo-1-methyl-1H-indol-3-yl)-3-(3,4,5-trimethoxyphenyl)-4,5-dihydro-1H-pyrazole-1-carboxamide] showed the most potent inhibitory effect on tubulin assembly (IC50=2.12m) and invitro growth inhibitory activity against a panel of four human cancer cell lines (IC50 values of 0.21-0.31m). Further studies confirmed that compound e19 can induce HeLa cell apoptosis, cause cell-cycle arrest in G(2)/M phase, and disrupt the cellular microtubule network. These studies, along with molecular docking and 3D-QSAR modeling, provide an important basis for further optimization of compound e19 as a potential anticancer agent.
What problem does this paper attempt to address?